Almost a year and a half has passed since the project, in which Cittadinanzattiva-ACN is a partner, started in January 2022 and #FACILITATE has remained true to its mission: to put patients at the center of the clinical trial process about the return and reuse of results after their involvement in a clinical trial. Research activities are ongoing, and legal, ethical, and regulatory studies are underway, internal meetings are held regularly, and expert decision-making committees have been set up.

Learn more about www.facilitate-project.eu

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034366.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.